|
TAS::75 0849::TAS ADMINISTRATIVE MODIFICATION
|
261200800001E
|
$313,286,406
|
|
DMITROVSKY, ETHAN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
Dana-Farber/Harvard Cancer Center
|
5P30CA006516-53
|
$11,504,298
|
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
5P30CA015704-43
|
$9,559,285
|
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
2P30CA033572-35
|
$2,543,187
|
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Translational Research in Breast Cancer (SPORE)
|
5P50CA186784-04
|
$2,300,000
|
$138,000
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
DF/HCC Kidney Cancer SPORE
|
5P50CA101942-13
|
$2,300,000
|
$276,000
|
MCDERMOTT, DAVID
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
SPORE in Cervical Cancer
|
5P50CA098252-14
|
$2,300,000
|
$299,000
|
WU, TZYY-CHOOU
|
JOHNS HOPKINS UNIVERSITY
|
|
SPORE in Skin Cancer
|
5P50CA174523-04
|
$2,300,000
|
$92,000
|
HERLYN, MEENHARD
|
WISTAR INSTITUTE
|
|
SPORE: Developing New Rationale, Personalized Medicine for Lung Cancer
|
5P50CA070907-19
|
$2,299,998
|
$460,000
|
MINNA, JOHN
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
SPORE in Prostate Cancer
|
5P50CA058236-22
|
$1,993,426
|
$398,685
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Adoptive Cell Transfer Immunotherapy of Cancer
|
ZIA BC 010984
|
$1,629,581
|
$651,832
|
Rosenberg, Steven
|
CCR (NCI)
|
|
Gene therapy of cancer
|
ZIA BC 010985
|
$1,629,581
|
$651,832
|
Rosenberg, Steven
|
CCR (NCI)
|
|
Building on the success of the adoptive immunotherapy of cancer
|
ZIA BC 010763
|
$1,562,883
|
$390,721
|
Restifo, Nicholas
|
CCR (NCI)
|
|
Cell Production Core Facility
|
ZIC BC 011569
|
$933,290
|
$466,645
|
Somerville, Robert
|
CCR (NCI)
|
|
Surgery Branch Cell Prep Core
|
ZIC BC 010905
|
$933,290
|
$466,645
|
Wunderlich, John
|
CCR (NCI)
|
|
Immuno-Targeted Therapy for Melanoma
|
5R35CA197633-03
|
$899,241
|
$269,772
|
RIBAS, ANTONI
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Cancer Center Support Grant
|
3P30CA033572-34S3
|
$865,000
|
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
T-cell receptor gene therapy for human papillomavirus-positive cancers
|
ZIA BC 011479
|
$671,060
|
$503,295
|
Hinrichs, Christian
|
CCR (NCI)
|
|
Clinical production of viral vectors for cancer gene therapy
|
ZIC BC 010989
|
$556,461
|
$556,461
|
Feldman, Steven
|
CCR (NCI)
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-53S1
|
$445,796
|
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
DICER1 and the Pleuropulmonary Blastoma Family Cancer Syndrome
|
5R01CA143167-07
|
$407,577
|
$407,577
|
HILL, DANA
|
CHILDREN'S RESEARCH INSTITUTE
|
|
CPRD: UK Resource for Epidemiologic Research
|
ZIA CP010144 10722
|
$362,499
|
|
Gadalla, Shahinaz
|
DCEG (NCI)
|
|
TGFbeta Blockade in MART TCR-Engineered T Cell Melanoma Immunotherapy in Man
|
5R01CA164333-05
|
$352,335
|
$176,168
|
KOYA, RICHARD
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Stem Cell Gene Therapy Following R-EPOCH for Non-Hodgkin Lymphoma in AIDS Patient
|
5U01CA183012-04
|
$312,304
|
$156,152
|
ZAIA, JOHN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Immune cell control of ovarian cancer
|
ZIA BC 011775
|
$309,150
|
$61,830
|
Annunziata, Christina
|
CCR (NCI)
|
|
Cancer Center Support Grant
|
3P30CA082103-19S3
|
$257,838
|
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA015704-43S3
|
$246,630
|
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-24S3
|
$246,169
|
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Cancer Center Support Grant
|
3P30CA042014-29S9
|
$228,331
|
|
ULRICH, CORNELIA
|
UNIVERSITY OF UTAH
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-53S6
|
$228,108
|
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
The Antigen Targeting Core
|
ZIC BC 011030
|
$225,010
|
$112,505
|
Parkhurst, Maria
|
CCR (NCI)
|
|
Cancer Center Support Grant
|
3P30CA015704-43S4
|
$225,000
|
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
3P30CA082103-19S2
|
$206,488
|
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-24S2
|
$200,000
|
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Cancer Center Support Grant
|
3P30CA015704-43S2
|
$199,999
|
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-53S7
|
$199,806
|
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
Stanford Cancer Institute
|
3P30CA124435-11S2
|
$171,518
|
|
ARTANDI, STEVEN
|
STANFORD UNIVERSITY
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-53S4
|
$149,528
|
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA014236-44S4
|
$119,106
|
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA015704-43S1
|
$78,024
|
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Development of fully-human anti-CD30 chimeric antigen receptors
|
ZIA BC 011660
|
$67,909
|
$67,909
|
Kochenderfer, James
|
CCR (NCI)
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-53S3
|
$62,500
|
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-53S5
|
$60,691
|
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-53S2
|
$59,495
|
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-24S4
|
$58,383
|
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Cancer Center Support Grant
|
3P30CA033572-35S1
|
$43,750
|
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
3P30CA014089-43S1
|
$40,593
|
|
FARNHAM, PEGGY
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Cancer Center Support Grant
|
3P30CA015704-43S5
|
$33,324
|
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Allogeneic T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor
|
ZIA BC 011415
|
$13,582
|
$2,716
|
Kochenderfer, James
|
CCR (NCI)
|
Total relevant funding to Gene Therapy Clinical Trials for this search: $6,605,745
|